nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—colon cancer	0.75	1	CbGaD
Tolvaptan—ABCB1—Irinotecan—colon cancer	0.036	0.284	CbGbCtD
Tolvaptan—ABCB1—Vincristine—colon cancer	0.0315	0.248	CbGbCtD
Tolvaptan—CYP3A4—Irinotecan—colon cancer	0.0216	0.17	CbGbCtD
Tolvaptan—ABCB1—Methotrexate—colon cancer	0.0191	0.15	CbGbCtD
Tolvaptan—CYP3A4—Vincristine—colon cancer	0.0189	0.149	CbGbCtD
Tolvaptan—Colitis ischaemic—Irinotecan—colon cancer	0.00584	0.0478	CcSEcCtD
Tolvaptan—Prothrombin level increased—Capecitabine—colon cancer	0.0028	0.0229	CcSEcCtD
Tolvaptan—Prurigo—Capecitabine—colon cancer	0.00249	0.0204	CcSEcCtD
Tolvaptan—Hyperuricaemia—Vincristine—colon cancer	0.0019	0.0156	CcSEcCtD
Tolvaptan—Deep vein thrombosis—Capecitabine—colon cancer	0.00189	0.0155	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Irinotecan—colon cancer	0.00182	0.0149	CcSEcCtD
Tolvaptan—Blood uric acid increased—Vincristine—colon cancer	0.0018	0.0147	CcSEcCtD
Tolvaptan—Respiratory failure—Vincristine—colon cancer	0.0018	0.0147	CcSEcCtD
Tolvaptan—Pulmonary embolism—Irinotecan—colon cancer	0.00172	0.0141	CcSEcCtD
Tolvaptan—Urine output increased—Vincristine—colon cancer	0.00159	0.0131	CcSEcCtD
Tolvaptan—Vaginal haemorrhage—Capecitabine—colon cancer	0.00155	0.0127	CcSEcCtD
Tolvaptan—Ventricular fibrillation—Capecitabine—colon cancer	0.0015	0.0123	CcSEcCtD
Tolvaptan—Polyuria—Vincristine—colon cancer	0.00146	0.0119	CcSEcCtD
Tolvaptan—Deep vein thrombosis—Methotrexate—colon cancer	0.00141	0.0115	CcSEcCtD
Tolvaptan—Renal impairment—Irinotecan—colon cancer	0.00131	0.0107	CcSEcCtD
Tolvaptan—Hyponatraemia—Vincristine—colon cancer	0.00129	0.0105	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Irinotecan—colon cancer	0.00127	0.0104	CcSEcCtD
Tolvaptan—Hyponatraemia—Irinotecan—colon cancer	0.00125	0.0102	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.00125	0.0102	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Capecitabine—colon cancer	0.00122	0.00995	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.00119	0.00978	CcSEcCtD
Tolvaptan—Dehydration—Vincristine—colon cancer	0.00119	0.00975	CcSEcCtD
Tolvaptan—Blood creatinine increased—Irinotecan—colon cancer	0.00117	0.00956	CcSEcCtD
Tolvaptan—Dehydration—Irinotecan—colon cancer	0.00116	0.00949	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00115	0.00944	CcSEcCtD
Tolvaptan—Pulmonary embolism—Capecitabine—colon cancer	0.00115	0.00941	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Irinotecan—colon cancer	0.00114	0.00932	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00112	0.00919	CcSEcCtD
Tolvaptan—Ecchymosis—Capecitabine—colon cancer	0.00104	0.00851	CcSEcCtD
Tolvaptan—Urine output increased—Capecitabine—colon cancer	0.00104	0.00851	CcSEcCtD
Tolvaptan—Polyuria—Capecitabine—colon cancer	0.00095	0.00778	CcSEcCtD
Tolvaptan—Renal failure—Irinotecan—colon cancer	0.000944	0.00773	CcSEcCtD
Tolvaptan—Hyperuricaemia—Methotrexate—colon cancer	0.000922	0.00755	CcSEcCtD
Tolvaptan—Thirst—Capecitabine—colon cancer	0.000877	0.00718	CcSEcCtD
Tolvaptan—Renal impairment—Capecitabine—colon cancer	0.000877	0.00718	CcSEcCtD
Tolvaptan—Urinary tract disorder—Vincristine—colon cancer	0.000875	0.00716	CcSEcCtD
Tolvaptan—Blood uric acid increased—Methotrexate—colon cancer	0.000871	0.00713	CcSEcCtD
Tolvaptan—Respiratory failure—Methotrexate—colon cancer	0.000871	0.00713	CcSEcCtD
Tolvaptan—Connective tissue disorder—Vincristine—colon cancer	0.00087	0.00712	CcSEcCtD
Tolvaptan—Urethral disorder—Vincristine—colon cancer	0.000868	0.00711	CcSEcCtD
Tolvaptan—Pulmonary embolism—Methotrexate—colon cancer	0.000856	0.00701	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Capecitabine—colon cancer	0.000851	0.00697	CcSEcCtD
Tolvaptan—Connective tissue disorder—Irinotecan—colon cancer	0.000848	0.00694	CcSEcCtD
Tolvaptan—Hyponatraemia—Capecitabine—colon cancer	0.000838	0.00686	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000834	0.00683	CcSEcCtD
Tolvaptan—Cardiac disorder—Vincristine—colon cancer	0.000822	0.00673	CcSEcCtD
Tolvaptan—Angiopathy—Vincristine—colon cancer	0.000804	0.00658	CcSEcCtD
Tolvaptan—Cardiac disorder—Irinotecan—colon cancer	0.0008	0.00655	CcSEcCtD
Tolvaptan—Mediastinal disorder—Vincristine—colon cancer	0.000798	0.00653	CcSEcCtD
Tolvaptan—Angiopathy—Irinotecan—colon cancer	0.000783	0.00641	CcSEcCtD
Tolvaptan—Blood creatinine increased—Capecitabine—colon cancer	0.000782	0.0064	CcSEcCtD
Tolvaptan—Immune system disorder—Irinotecan—colon cancer	0.000779	0.00638	CcSEcCtD
Tolvaptan—Mediastinal disorder—Irinotecan—colon cancer	0.000777	0.00636	CcSEcCtD
Tolvaptan—Dehydration—Capecitabine—colon cancer	0.000776	0.00635	CcSEcCtD
Tolvaptan—Ecchymosis—Methotrexate—colon cancer	0.000774	0.00633	CcSEcCtD
Tolvaptan—Urine output increased—Methotrexate—colon cancer	0.000774	0.00633	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Capecitabine—colon cancer	0.000762	0.00624	CcSEcCtD
Tolvaptan—Breast disorder—Capecitabine—colon cancer	0.000754	0.00617	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000751	0.00615	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000736	0.00602	CcSEcCtD
Tolvaptan—Polyuria—Methotrexate—colon cancer	0.000707	0.00579	CcSEcCtD
Tolvaptan—Ill-defined disorder—Irinotecan—colon cancer	0.000697	0.0057	CcSEcCtD
Tolvaptan—Malaise—Irinotecan—colon cancer	0.000677	0.00554	CcSEcCtD
Tolvaptan—Syncope—Irinotecan—colon cancer	0.000673	0.00551	CcSEcCtD
Tolvaptan—Loss of consciousness—Irinotecan—colon cancer	0.00066	0.0054	CcSEcCtD
Tolvaptan—Hyperglycaemia—Capecitabine—colon cancer	0.000651	0.00533	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Methotrexate—colon cancer	0.000634	0.00519	CcSEcCtD
Tolvaptan—Renal failure—Capecitabine—colon cancer	0.000632	0.00517	CcSEcCtD
Tolvaptan—Discomfort—Irinotecan—colon cancer	0.000632	0.00517	CcSEcCtD
Tolvaptan—Anaphylactic shock—Vincristine—colon cancer	0.000629	0.00515	CcSEcCtD
Tolvaptan—Nervous system disorder—Vincristine—colon cancer	0.000617	0.00505	CcSEcCtD
Tolvaptan—Anaphylactic shock—Irinotecan—colon cancer	0.000613	0.00502	CcSEcCtD
Tolvaptan—Discomfort—Fluorouracil—colon cancer	0.000605	0.00495	CcSEcCtD
Tolvaptan—Shock—Irinotecan—colon cancer	0.000603	0.00494	CcSEcCtD
Tolvaptan—Nervous system disorder—Irinotecan—colon cancer	0.000601	0.00492	CcSEcCtD
Tolvaptan—Anorexia—Vincristine—colon cancer	0.0006	0.00491	CcSEcCtD
Tolvaptan—Anaphylactic shock—Fluorouracil—colon cancer	0.000587	0.0048	CcSEcCtD
Tolvaptan—Anorexia—Irinotecan—colon cancer	0.000584	0.00478	CcSEcCtD
Tolvaptan—Nervous system disorder—Fluorouracil—colon cancer	0.000576	0.00471	CcSEcCtD
Tolvaptan—Urinary tract disorder—Capecitabine—colon cancer	0.00057	0.00467	CcSEcCtD
Tolvaptan—Connective tissue disorder—Capecitabine—colon cancer	0.000567	0.00464	CcSEcCtD
Tolvaptan—Urethral disorder—Capecitabine—colon cancer	0.000566	0.00463	CcSEcCtD
Tolvaptan—Breast disorder—Methotrexate—colon cancer	0.000561	0.0046	CcSEcCtD
Tolvaptan—Anorexia—Fluorouracil—colon cancer	0.000559	0.00458	CcSEcCtD
Tolvaptan—Decreased appetite—Vincristine—colon cancer	0.000547	0.00448	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Vincristine—colon cancer	0.000543	0.00445	CcSEcCtD
Tolvaptan—Constipation—Vincristine—colon cancer	0.000538	0.0044	CcSEcCtD
Tolvaptan—Cardiac disorder—Capecitabine—colon cancer	0.000536	0.00439	CcSEcCtD
Tolvaptan—Decreased appetite—Irinotecan—colon cancer	0.000533	0.00436	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Irinotecan—colon cancer	0.000529	0.00433	CcSEcCtD
Tolvaptan—Constipation—Irinotecan—colon cancer	0.000524	0.00429	CcSEcCtD
Tolvaptan—Angiopathy—Capecitabine—colon cancer	0.000524	0.00429	CcSEcCtD
Tolvaptan—Immune system disorder—Capecitabine—colon cancer	0.000521	0.00427	CcSEcCtD
Tolvaptan—Mediastinal disorder—Capecitabine—colon cancer	0.00052	0.00426	CcSEcCtD
Tolvaptan—Decreased appetite—Fluorouracil—colon cancer	0.00051	0.00418	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000507	0.00415	CcSEcCtD
Tolvaptan—Feeling abnormal—Irinotecan—colon cancer	0.000505	0.00413	CcSEcCtD
Tolvaptan—Malnutrition—Capecitabine—colon cancer	0.000502	0.00411	CcSEcCtD
Tolvaptan—Body temperature increased—Vincristine—colon cancer	0.000497	0.00407	CcSEcCtD
Tolvaptan—Dysgeusia—Capecitabine—colon cancer	0.000492	0.00403	CcSEcCtD
Tolvaptan—Body temperature increased—Irinotecan—colon cancer	0.000484	0.00397	CcSEcCtD
Tolvaptan—Feeling abnormal—Fluorouracil—colon cancer	0.000484	0.00396	CcSEcCtD
Tolvaptan—Renal failure—Methotrexate—colon cancer	0.000471	0.00385	CcSEcCtD
Tolvaptan—Ill-defined disorder—Capecitabine—colon cancer	0.000466	0.00382	CcSEcCtD
Tolvaptan—Body temperature increased—Fluorouracil—colon cancer	0.000464	0.0038	CcSEcCtD
Tolvaptan—Hypersensitivity—Vincristine—colon cancer	0.000464	0.00379	CcSEcCtD
Tolvaptan—Malaise—Capecitabine—colon cancer	0.000453	0.00371	CcSEcCtD
Tolvaptan—Hypersensitivity—Irinotecan—colon cancer	0.000451	0.0037	CcSEcCtD
Tolvaptan—Asthenia—Vincristine—colon cancer	0.000451	0.0037	CcSEcCtD
Tolvaptan—Syncope—Capecitabine—colon cancer	0.000451	0.00369	CcSEcCtD
Tolvaptan—Loss of consciousness—Capecitabine—colon cancer	0.000442	0.00362	CcSEcCtD
Tolvaptan—Asthenia—Irinotecan—colon cancer	0.00044	0.0036	CcSEcCtD
Tolvaptan—Hypersensitivity—Fluorouracil—colon cancer	0.000432	0.00354	CcSEcCtD
Tolvaptan—Diarrhoea—Vincristine—colon cancer	0.00043	0.00352	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000425	0.00348	CcSEcCtD
Tolvaptan—Urinary tract disorder—Methotrexate—colon cancer	0.000424	0.00347	CcSEcCtD
Tolvaptan—Discomfort—Capecitabine—colon cancer	0.000423	0.00346	CcSEcCtD
Tolvaptan—Urethral disorder—Methotrexate—colon cancer	0.000421	0.00345	CcSEcCtD
Tolvaptan—Diarrhoea—Irinotecan—colon cancer	0.000419	0.00343	CcSEcCtD
Tolvaptan—Dry mouth—Capecitabine—colon cancer	0.000418	0.00343	CcSEcCtD
Tolvaptan—Dizziness—Vincristine—colon cancer	0.000416	0.00341	CcSEcCtD
Tolvaptan—Pruritus—Fluorouracil—colon cancer	0.000415	0.0034	CcSEcCtD
Tolvaptan—Dizziness—Irinotecan—colon cancer	0.000405	0.00332	CcSEcCtD
Tolvaptan—Shock—Capecitabine—colon cancer	0.000403	0.0033	CcSEcCtD
Tolvaptan—Nervous system disorder—Capecitabine—colon cancer	0.000402	0.00329	CcSEcCtD
Tolvaptan—Diarrhoea—Fluorouracil—colon cancer	0.000402	0.00329	CcSEcCtD
Tolvaptan—Cardiac disorder—Methotrexate—colon cancer	0.000399	0.00326	CcSEcCtD
Tolvaptan—Vismodegib—ABCB1—colon cancer	0.000399	1	CrCbGaD
Tolvaptan—Skin disorder—Capecitabine—colon cancer	0.000398	0.00326	CcSEcCtD
Tolvaptan—Headache—Vincristine—colon cancer	0.000394	0.00323	CcSEcCtD
Tolvaptan—Anorexia—Capecitabine—colon cancer	0.000391	0.0032	CcSEcCtD
Tolvaptan—Angiopathy—Methotrexate—colon cancer	0.00039	0.00319	CcSEcCtD
Tolvaptan—Immune system disorder—Methotrexate—colon cancer	0.000388	0.00318	CcSEcCtD
Tolvaptan—Dizziness—Fluorouracil—colon cancer	0.000388	0.00318	CcSEcCtD
Tolvaptan—Mediastinal disorder—Methotrexate—colon cancer	0.000387	0.00317	CcSEcCtD
Tolvaptan—Headache—Irinotecan—colon cancer	0.000384	0.00314	CcSEcCtD
Tolvaptan—Malnutrition—Methotrexate—colon cancer	0.000374	0.00306	CcSEcCtD
Tolvaptan—Nausea—Vincristine—colon cancer	0.000374	0.00306	CcSEcCtD
Tolvaptan—Headache—Fluorouracil—colon cancer	0.000368	0.00301	CcSEcCtD
Tolvaptan—Dysgeusia—Methotrexate—colon cancer	0.000366	0.003	CcSEcCtD
Tolvaptan—Nausea—Irinotecan—colon cancer	0.000364	0.00298	CcSEcCtD
Tolvaptan—Decreased appetite—Capecitabine—colon cancer	0.000357	0.00292	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Capecitabine—colon cancer	0.000354	0.0029	CcSEcCtD
Tolvaptan—Constipation—Capecitabine—colon cancer	0.000351	0.00287	CcSEcCtD
Tolvaptan—Nausea—Fluorouracil—colon cancer	0.000349	0.00285	CcSEcCtD
Tolvaptan—Ill-defined disorder—Methotrexate—colon cancer	0.000347	0.00284	CcSEcCtD
Tolvaptan—Feeling abnormal—Capecitabine—colon cancer	0.000338	0.00277	CcSEcCtD
Tolvaptan—Malaise—Methotrexate—colon cancer	0.000337	0.00276	CcSEcCtD
Tolvaptan—Body temperature increased—Capecitabine—colon cancer	0.000324	0.00265	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000316	0.00259	CcSEcCtD
Tolvaptan—Discomfort—Methotrexate—colon cancer	0.000315	0.00258	CcSEcCtD
Tolvaptan—Anaphylactic shock—Methotrexate—colon cancer	0.000305	0.0025	CcSEcCtD
Tolvaptan—Hypersensitivity—Capecitabine—colon cancer	0.000302	0.00247	CcSEcCtD
Tolvaptan—Nervous system disorder—Methotrexate—colon cancer	0.000299	0.00245	CcSEcCtD
Tolvaptan—Skin disorder—Methotrexate—colon cancer	0.000297	0.00243	CcSEcCtD
Tolvaptan—Asthenia—Capecitabine—colon cancer	0.000294	0.00241	CcSEcCtD
Tolvaptan—Anorexia—Methotrexate—colon cancer	0.000291	0.00238	CcSEcCtD
Tolvaptan—Pruritus—Capecitabine—colon cancer	0.00029	0.00238	CcSEcCtD
Tolvaptan—Diarrhoea—Capecitabine—colon cancer	0.000281	0.0023	CcSEcCtD
Tolvaptan—Dizziness—Capecitabine—colon cancer	0.000271	0.00222	CcSEcCtD
Tolvaptan—Decreased appetite—Methotrexate—colon cancer	0.000265	0.00217	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Methotrexate—colon cancer	0.000264	0.00216	CcSEcCtD
Tolvaptan—Headache—Capecitabine—colon cancer	0.000257	0.0021	CcSEcCtD
Tolvaptan—Feeling abnormal—Methotrexate—colon cancer	0.000252	0.00206	CcSEcCtD
Tolvaptan—Nausea—Capecitabine—colon cancer	0.000244	0.00199	CcSEcCtD
Tolvaptan—Body temperature increased—Methotrexate—colon cancer	0.000241	0.00198	CcSEcCtD
Tolvaptan—Hypersensitivity—Methotrexate—colon cancer	0.000225	0.00184	CcSEcCtD
Tolvaptan—Asthenia—Methotrexate—colon cancer	0.000219	0.00179	CcSEcCtD
Tolvaptan—Pruritus—Methotrexate—colon cancer	0.000216	0.00177	CcSEcCtD
Tolvaptan—Diarrhoea—Methotrexate—colon cancer	0.000209	0.00171	CcSEcCtD
Tolvaptan—Dizziness—Methotrexate—colon cancer	0.000202	0.00165	CcSEcCtD
Tolvaptan—Headache—Methotrexate—colon cancer	0.000191	0.00157	CcSEcCtD
Tolvaptan—Nausea—Methotrexate—colon cancer	0.000181	0.00148	CcSEcCtD
